SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-298535
Filing Date
2022-12-05
Accepted
2022-12-05 17:12:10
Documents
16
Period of Report
2022-11-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d393902d8k.htm   iXBRL 8-K 31338
2 EX-1.1 d393902dex11.htm EX-1.1 243176
3 EX-5.1 d393902dex51.htm EX-5.1 7075
7 GRAPHIC g393902dsp0001ajpg.jpg GRAPHIC 10923
8 GRAPHIC g393902dsp0001jpg.jpg GRAPHIC 7646
  Complete submission text file 0001193125-22-298535.txt   500030

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aura-20221130.xsd EX-101.SCH 2862
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aura-20221130_lab.xml EX-101.LAB 17978
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aura-20221130_pre.xml EX-101.PRE 11266
10 EXTRACTED XBRL INSTANCE DOCUMENT d393902d8k_htm.xml XML 3339
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40971 | Film No.: 221445812
SIC: 2836 Biological Products, (No Diagnostic Substances)